Urabe M - Search Results

1

Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.

Urabe M, Ushiku T, Shinozaki-Ushiku A, Iwasaki A, Yamazawa S, Yamashita H, Seto Y, Fukayama M. Urabe M, et al. Cancer Med. 2018 Oct;7(10):5145-5154. doi: 10.1002/cam4.1763. Epub 2018 Sep 21. Cancer Med. 2018. PMID: 30239168 Free PMC article.

2

Solitary fibrous tumor of the greater omentum, mimicking gastrointestinal stromal tumor of the small intestine: a case report.

Urabe M, Yamagata Y, Aikou S, Mori K, Yamashita H, Nomura S, Shibahara J, Fukayama M, Seto Y. Urabe M, et al. Int Surg. 2015 May;100(5):836-40. doi: 10.9738/INTSURG-D-14-00141.1. Int Surg. 2015. PMID: 26011203 Free PMC article.

3

Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens.

Matsusaka K, Ishikawa S, Nakayama A, Ushiku T, Nishimoto A, Urabe M, Kaneko N, Kunita A, Kaneda A, Aburatani H, Fujishiro M, Seto Y, Fukayama M. Matsusaka K, et al. Among authors: urabe m. PLoS One. 2016 Apr 27;11(4):e0154430. doi: 10.1371/journal.pone.0154430. eCollection 2016. PLoS One. 2016. PMID: 27119558 Free PMC article.

4

Pathologic Response of HER2-positive Gastric Cancer to Trastuzumab-based Chemotherapy.

Urabe M, Ushiku T, Seto Y, Fukayama M. Urabe M, et al. Am J Surg Pathol. 2016 Oct;40(10):1326-33. doi: 10.1097/PAS.0000000000000672. Am J Surg Pathol. 2016. PMID: 27259008

5

Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.

Saju P, Murata-Kamiya N, Hayashi T, Senda Y, Nagase L, Noda S, Matsusaka K, Funata S, Kunita A, Urabe M, Seto Y, Fukayama M, Kaneda A, Hatakeyama M. Saju P, et al. Among authors: urabe m. Nat Microbiol. 2016 Mar 14;1:16026. doi: 10.1038/nmicrobiol.2016.26. Nat Microbiol. 2016. PMID: 27572445

6

Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer.

Matsusaka K, Ushiku T, Urabe M, Fukuyo M, Abe H, Ishikawa S, Seto Y, Aburatani H, Hamakubo T, Kaneda A, Fukayama M. Matsusaka K, et al. Among authors: urabe m. Oncotarget. 2016 Sep 27;7(39):64168-64181. doi: 10.18632/oncotarget.11638. Oncotarget. 2016. PMID: 27580354 Free PMC article.

7

Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.

Urabe M, Yamashita H, Watanabe T, Seto Y. Urabe M, et al. World J Surg. 2018 Jan;42(1):185-194. doi: 10.1007/s00268-017-4146-9. World J Surg. 2018. PMID: 28741195

8

Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Patients With Resectable Gastroesophageal Junction and Gastric Cancer.

Urabe M, Yamashita H, Seto Y. Urabe M, et al. Ann Surg. 2017 Dec;266(6):e76-e77. doi: 10.1097/SLA.0000000000001596. Ann Surg. 2017. PMID: 29136992 No abstract available.

9

Gastric cancer with solitary liver metastasis accompanied by cyst formation.

Urabe M, Yamashita H, Akamatsu N, Seto Y. Urabe M, et al. ANZ J Surg. 2019 Jun;89(6):784-785. doi: 10.1111/ans.14315. Epub 2017 Dec 11. ANZ J Surg. 2019. PMID: 29228511 No abstract available.

10

Non-linear association between long-term outcome and preoperative neutrophil-to-lymphocyte ratio in patients undergoing curative resection for gastric cancer: a retrospective analysis of 1335 cases in a tetrachotomous manner.

Urabe M, Yamashita H, Uemura Y, Tanabe A, Yagi K, Aikou S, Seto Y. Urabe M, et al. Jpn J Clin Oncol. 2018 Apr 1;48(4):343-349. doi: 10.1093/jjco/hyy005. Jpn J Clin Oncol. 2018. PMID: 29420755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters